======= PHC1 ======= == Gene Information == * **Official Symbol**: PHC1 * **Official Name**: polyhomeotic homolog 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1911|1911]] * **UniProt**: [[https://www.uniprot.org/uniprot/P78364|P78364]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PHC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHC1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602978|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a homolog of the Drosophila polyhomeotic gene, which is a member of the Polycomb group of genes. The gene product is a component of a multimeric protein complex that contains EDR2 and the vertebrate Polycomb protein BMH1. The gene product, the EDR2 protein, and the Drosophila polyhomeotic protein share 2 highly conserved domains, named homology domains I and II. These domains are involved in protein-protein interactions and may mediate heterodimerization of the protein encoded by this gene and the EDR2 protein. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Required for proper control of cellular levels of GMNN expression. {ECO:0000269|PubMed:23418308}. |SAM 1| |SAM 2| |PRC1 complex| |PcG protein complex| |negative regulation of G0 to G1 transition| |histone ubiquitination| |regulation of G0 to G1 transition| |negative regulation of cell cycle process| |histone modification| |covalent chromatin modification| |negative regulation of cell cycle| |protein ubiquitination| |chromatin organization| |regulation of cell cycle process| |protein modification by small protein conjugation| |zinc ion binding| |protein modification by small protein conjugation or removal| |chromosome organization| |regulation of cell cycle| |DNA binding| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|-1.97| |[[:results:exp59|UMK57 1μM R01 exp59]]|-1.84| |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|-1.75| |[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.73| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.94| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.65| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18865 * **Expression level (log2 read counts)**: 5.95 {{:chemogenomics:nalm6 dist.png?nolink |}}